Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS

Bach Xuan Tran, Long Thanh Nguyen, Cuong Duy Do, Quyen Le Nguyen, Rachel Marie Maher, Bach Xuan Tran, Long Thanh Nguyen, Cuong Duy Do, Quyen Le Nguyen, Rachel Marie Maher

Abstract

Background: We examined the association of alcohol use disorders (AUD) with adherence to and health-related quality of life (HRQOL) outcomes of antiretroviral treatment (ART) for HIV/AIDS patients.

Methods: A cross-sectional multi-site survey was conducted in 468 drug users and 648 non-drug users (age: 35.4 ± 7.0 years; 63.8% male) in 3 epicentres of Vietnam. AUD, ART adherence, and HRQOL were measured using the Alcohol Use Disorders Identification Test - Consumption (AUDIT-C), the self-reported Visual Analogue Scale (VAS), and the World Health Organization Quality of Life instrument (WHOQOL-HIV BREF).

Results: 35.0% of drug users were hazardous drinkers, compared to 25.9% of non-drug users. 22.3% of drug users engaged in binge drinking, and 25.9% reported suboptimal ART adherence. Adjusting for propensity scores of AUD, patients who had either at-risk or binge drinking behaviour were about twice as likely to be treatment non-adherent as those who did not have AUD. Hazardous drinkers reported small to medium decrements in the Performance, Physical, Social, Spirituality, and Environment quality of life domains. Binge drinkers had a slightly higher score in Social dimension.

Conclusion: AUD is prevalent and negatively affecting adherence to and HRQOL outcomes of ART services in injection-driven HIV epidemics. Screening and intervention are recommended for AUD, especially during the stable periods of ART. Other social and psychological interventions might also enhance patients' responses to and outcomes of ART in Vietnam.

Figures

Figure 1
Figure 1
HRQOL of HIV/AIDS patients at different periods of ART. a. HRQOL of HIV/AIDS patients without AUD during ART. b. HRQOL of HIV/AIDS patients with AUD during ART.

References

    1. Schneider M, Chersich M, Neuman M, Parry C. Alcohol consumption and HIV/AIDS: the neglected interface. Addiction. 2012;107(8):1369–1371. doi: 10.1111/j.1360-0443.2012.03824.x.
    1. Mimiaga MJ, Thomas B, Mayer KH, Reisner SL, Menon S, Swaminathan S, Periyasamy M, Johnson CV, Safren SA. Alcohol use and HIV sexual risk among MSM in Chennai, India. Int J STD AIDS. 2011;22(3):121–125. doi: 10.1258/ijsa.2009.009059.
    1. Schensul JJ, Singh SK, Gupta K, Bryant K, Verma R. Alcohol and HIV in India: a review of current research and intervention. AIDS Behav. 2010;14(Suppl 1):S1–7.
    1. The Commission on AIDS in Asia. Redefining AIDS in Asia: crafting an effective response. Oxford University Press; 2008. p. 258. Available at . Accessed November 1, 2012.
    1. Neuman MG, Monteiro M, Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse. 2006;41(10–12):1395–1463.
    1. Ferrari LF, Levine JD. Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms. Eur J Neurosci. 2010;32(5):811–818. doi: 10.1111/j.1460-9568.2010.07355.x.
    1. Cheng DM, Libman H, Bridden C, Saitz R, Samet JH. Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems. Alcohol. 2009;43(1):65–71. doi: 10.1016/j.alcohol.2008.09.004.
    1. Ghebremichael M, Paintsil E, Ickovics JR, Vlahov D, Schuman P, Boland R, Schoenbaum E, Moore J, Zhang H. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;21(7):834–841. doi: 10.1080/09540120802537864.
    1. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, Houston S, Jacobs P. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam’s injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125(3):260–266. doi: 10.1016/j.drugalcdep.2012.02.021.
    1. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Mills S, Houston S, Jacobs P. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care. 2012;24(3):283–290. doi: 10.1080/09540121.2011.608420.
    1. Tran BX, Nguyen N, Ohinmaa A, Duong AT, Nguyen LT, Van Hoang M, Vu PX, Veugelers PJ. Prevalence and correlates of alcohol use disorders during antiretroviral treatment in injection-driven HIV epidemics in Vietnam. Drug Alcohol Depend. 2013;127(1-3):39–44. doi: 10.1016/j.drugalcdep.2012.06.009.
    1. Ezard N, Oppenheimer E, Burton A, Schilperoord M, Macdonald D, Adelekan M, Sakarati A, van Ommeren M. Six rapid assessments of alcohol and other substance use in populations displaced by conflict. Confl Health. 2011;5(1):1. doi: 10.1186/1752-1505-5-1.
    1. Neramitpitagkul P, Lertpitakpong C, Yothasamut J, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y. Economic impact on health-care costs related to major diseases including HIV/AIDS due to alcohol drinking among Thai populations. Value Health. 2009;12(Suppl 3):S97–S100.
    1. le Tho H, Singhasivanon P, Kaewkungwal J, Kaljee LM, Charoenkul C. Sexual behaviors of alcohol drinkers and non-drinkers among adolescents and young adults in Nha Trang, Vietnam. Southeast Asian J Trop Med Public Health. 2007;38(1):152–160.
    1. Luo XF, Duan S, Duan QX, Pu YC, Yang YC, Wong FY, He N. Prevalence and correlates of alcohol use and subsequent sexual activity among adult males in a rural community of ethnic minorities in Yunnan Province, China. Biosci Trends. 2012;6(6):288–295.
    1. Li Q, Li X, Stanton B. Alcohol use and sexual risk behaviors and outcomes in China: a literature review. AIDS Behav. 2010;14(6):1227–1236. doi: 10.1007/s10461-009-9648-5.
    1. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, Houston S, Jacobs P. The cost-effectiveness and budget impact of Vietnam’s methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Glob Public Health. 2012;7(10):1080–1094. doi: 10.1080/17441692.2012.736259.
    1. Tran DA, Shakeshaft A, Ngo AD, Mallitt KA, Wilson D, Doran C, Zhang L. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam. HIV Clin Trials. 2013;14(1):21–33. doi: 10.1310/hct1401-21.
    1. Tran BX, Nguyen LT, Nguyen NH, Hoang QV, Hwang J. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action. 2013;6:19570.
    1. DA C d, Thorson A, Sonnerborg Hoa NP, Chuc NT, Phuc HD, Larsson M. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam. Scand J Infect Dis. 2012;44(3):201–208. doi: 10.3109/00365548.2011.631937.
    1. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Nguyen QC, Mills S, Jacobs P, Houston S. Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS. Qual Life Res. 2012;21(4):613–623. doi: 10.1007/s11136-011-9963-y.
    1. Van Tam V, Larsson M, Pharris A, Diedrichs B, Nguyen HP, Nguyen CT, Ho PD, Marrone G, Thorson A. Peer support and improved quality of life among persons living with HIV on antiretroviral treatment: a randomised controlled trial from north-eastern Vietnam. Health Qual Life Outcomes. 2012;10:53. doi: 10.1186/1477-7525-10-53.
    1. Tran BX, Ohinmaa A, Nguyen LT, Nguyen TA, Nguyen TH. Determinants of health-related quality of life in adults living with HIV in Vietnam. AIDS Care. 2011;23(10):1236–1245. doi: 10.1080/09540121.2011.555749.
    1. Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5 L in HIV/AIDS patients. Health Qual Life Outcomes. 2012;10(1):132. doi: 10.1186/1477-7525-10-132.
    1. Tran BX, Nguyen NPT. Patient Satisfaction with HIV/AIDS Care and Treatment in the Decentralization of Services Delivery in Vietnam. PLoS One. 2012;7(10):e46680. doi: 10.1371/journal.pone.0046680.
    1. Giang KB, Allebeck P, Spak F, Van Minh H, Dzung TV. Alcohol use and alcohol consumption-related problems in rural Vietnam: an epidemiological survey using AUDIT. Subst Use Misuse. 2008;43(3–4):481–495.
    1. Broyles LM, Gordon AJ, Sereika SM, Ryan CM, Erlen JA. Predictive Utility of Brief Alcohol Use Disorders Identification Test (AUDIT) for human immunodeficiency virus antiretroviral medication nonadherence. Subst Abus. 2011;32(4):252–261. doi: 10.1080/08897077.2011.599255.
    1. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–79. doi: 10.1310/JFXH-G3X2-EYM6-D6UG.
    1. WHOQOL HIV Group. WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: results from the field test. AIDS Care. 2004;16(7):882–889. doi: 10.1080/09540120412331290194.
    1. O’Connell K, Skevington S, Saxena S. Preliminary development of the World Health Organsiation’s Quality of Life HIV instrument (WHOQOL-HIV): analysis of the pilot version. Soc Sci Med. 2003;57(7):1259–1275.
    1. Tran BX, Ohinmaa A, Nguyen LT, Oosterhoff P, Vu PX, Vu TV, Larsson M. Gender differences in quality of life outcomes of HIV/AIDS treatment in the latent feminization of HIV epidemics in Vietnam. AIDS Care. 2012;24(10):1187–1196. doi: 10.1080/09540121.2012.658752.
    1. Tran BX. Quality of life outcomes of antiretroviral treatment for HIV/AIDS patients in Vietnam. PLoS One. 2012;7(7):e41062. doi: 10.1371/journal.pone.0041062.
    1. Linden A, Adams JL. Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data. J Eval Clin Pract. 2010;16(1):180–185. doi: 10.1111/j.1365-2753.2009.01361.x.
    1. Lu B. Propensity score matching with time-dependent covariates. Biometrics. 2005;61(3):721–728. doi: 10.1111/j.1541-0420.2005.00356.x.
    1. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9(8):901–910. doi: 10.1023/A:1008938326604.
    1. Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–193. doi: 10.1016/j.drugalcdep.2010.06.014.
    1. Senbanjo R, Wolff K, Marshall J. Excessive alcohol consumption is associated with reduced quality of life among methadone patients. Addiction. 2007;102(2):257–263. doi: 10.1111/j.1360-0443.2006.01683.x.
    1. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Nguyen QC, Mills S, Jacobs P, Houston S. Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS. Qual Life Res. 2011;21(4):613–623.
    1. Tuunanen M, Aalto M, Seppa K. Binge drinking and its detection among middle-aged men using AUDIT, AUDIT-C and AUDIT-3. Drug Alcohol Rev. 2007;26(3):295–299. doi: 10.1080/09595230701247756.
    1. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–1217. doi: 10.1111/j.1530-0277.2007.00403.x.
    1. Frank D, DeBenedetti AF, Volk RJ, Williams EC, Kivlahan DR, Bradley KA. Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med. 2008;23(6):781–787. doi: 10.1007/s11606-008-0594-0.
    1. Mai Do Hoa MD. Pham Viet Cuong. ART adherence among people living with HIV/AIDS in Ha Noi and Hai Duong: situation and associated factors. J Pract Med, Hanoi. 2010;243&243(2011):5.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe